Characterizing the Role of 1p36 Deletion in Breast Cancer and Identifying Candidate Tumor Suppressors
Annual summary, 1 Apr 2006-31 Mar 2007
CALIFORNIA UNIV SAN FRANCISCO
Pagination or Media Count:
Over 60 of human breast tumors display a deletion of one copy of the 1p36 region of the short arm of chromosome 1. Tumors with this deletion show a three-fold increase in mortality, suggesting a biological role for this deletion in tumor development, and suggesting the presence of one or more tumor suppressors in this region. Purpose Characterization of the unique biology of tumors with 1p36 deletion, and characterization of the tumor suppressors in the region may inform therapeutic strategies, and present unique therapeutic targets for this subset of breast cancer cases with relatively poor survival. Scope The goals of this research project are to 1 develop a mouse model for 1p36 deletion in breast cancer by generating mice harboring IoxP sequences flanking the deletion region, and crossing to tissue-specific Cre expressing mice, 2 perform in-vivo insertional mutagenesis in breast tumors using the two-component Sleeping Beauty transposon system mutagenic transposons mobilized by a trans-acting transposase to tag tumor suppressors and oncogenes during tumor development and 3 to combine these two systems to identify tumor suppressors in the 1p36 region. To date, we have acquired targeting constructs, generated cohorts of mice for insertional mutagenesis, and developed in vitro alternative approaches.
- Genetic Engineering and Molecular Biology
- Medicine and Medical Research